Prescription drug prices have skyrocketed in the past decade.
A new report says the price of a generic version of an insulin drug has quadrupled in the last decade, and that prices for other drugs like fluoxetine, an anti-depressant, have doubled.
The price of those drugs has also risen more than 20 percent, according to the report from the nonprofit Kaiser Family Foundation.
That is more than the increase of 9 percent for generic drugs, which are cheaper to produce.
The drugmaker said its prices were based on a cost-benefit analysis that included price increases in new treatments and new treatments in the same drug category that were cheaper.
Kaiser’s analysis is not the only study showing an increase in drug prices, said John Donohue, the co-author of the Kaiser report.
Other studies also found price increases.
The Journal of the American Medical Association published a report last year saying drug prices increased by 30 percent between 2003 and 2017.
The report said the increase was due to a rise in prescription drug prices and an increase of 6.5 million prescriptions filled.
The rise in prescriptions for generic versions of the drugs had slowed.
But the increase in the price for the generic version has been so great that the price has risen more quickly than the generic, Kaiser found.
“The trend of the increase is really disturbing,” said Donohu.
“I think it is an alarming trend that we need to do something about.”
The study found that generic drugs account for less than 2 percent of the overall market for the drugs, while brand name drugs account a third.
Kraft Heinz Co., which makes the brand name products, has been the target of criticism from lawmakers and others in recent years.
In January, President Donald Trump ordered the company to slash $2 billion from the cost of the brand-name products and to increase the prices of brand-new products by 10 percent.
Trump and some lawmakers have also proposed eliminating the Affordable Care Act’s requirement that companies that make generic versions, like Pfizer Inc., provide them at no extra cost.
Pfizer says its price increases are driven by increased demand for generic medicines, as well as a shortage of the drug.
In addition to being a key player in the industry, Pfizer also has faced criticism for what critics say are inflated prices for some of its products.
Critics also point to the increasing prices for prescription drugs for conditions like cancer and diabetes.